Mitro et al. showed that an LXR agonist (GW3965) can increase the gene expression of myelin basic protein (MBP), which is a protein believed to be important in the myelination of nerves in the central nervous system (CNS), in steroidal diabetes model rats (Mitro et al., 2012). Here, MBP is linked to diabetes mellitus.